Back to Search
Start Over
Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo
- Source :
- Stem Cell Reports, Stem cell reports 12(3), 502-517 (2019). doi:10.1016/j.stemcr.2019.01.015, Stem Cell Reports, Vol 12, Iss 3, Pp 502-517 (2019)
- Publication Year :
- 2019
-
Abstract
- Summary Neuroinflammation is a hallmark of neurological disorders and is accompanied by the production of neurotoxic agents such as nitric oxide. We used stem cell-based phenotypic screening and identified small molecules that directly protected neurons from neuroinflammation-induced degeneration. We demonstrate that inhibition of CDK5 is involved in, but not sufficient for, neuroprotection. Instead, additional inhibition of GSK3β is required to enhance the neuroprotective effects of CDK5 inhibition, which was confirmed using short hairpin RNA-mediated knockdown of CDK5 and GSK3β. Quantitative phosphoproteomics and high-content imaging demonstrate that neurite degeneration is mediated by aberrant phosphorylation of multiple microtubule-associated proteins. Finally, we show that our hit compound protects neurons in vivo in zebrafish models of motor neuron degeneration and Alzheimer's disease. Thus, we demonstrate an overlap of CDK5 and GSK3β in mediating the regulation of the neuronal cytoskeleton and that our hit compound LDC8 represents a promising starting point for neuroprotective drugs.<br />Highlights • Phenotypic screening identifies CDK inhibitors protecting neurons from inflammation • Inhibition of CDK5 is involved in neuroprotection but is not sufficient • Dual inhibition of CDK5 and GSK3β is neuroprotective in vitro and in vivo • Quantitative phosphoproteomics links neuroprotection to microtubule dynamics<br />Neuroinflammation is a hallmark of many neurological disorders and can be neurotoxic. Sterneckert and colleagues perform a phenotypic screening campaign identifying compounds protecting motor neurons from inflammation. Compound profiling demonstrates that dual inhibition of CDK5 and GSK3β mediates neuroprotection. Quantitative phosphoproteomics demonstrates that neuroprotection is linked to alterations in microtubule dynamics mediated by phosphorylation of microtubule-associated proteins.
- Subjects :
- 0301 basic medicine
metabolism [Cytoskeleton]
Biochemistry
Microtubules
neuroinflammation
0302 clinical medicine
drug therapy [Alzheimer Disease]
stem cell-based phenotypic screening
metabolism [Zebrafish]
Phosphorylation
lcsh:QH301-705.5
Zebrafish
metabolism [Nerve Degeneration]
Cytoskeleton
Neurons
lcsh:R5-920
metabolism [Inflammation]
Neurodegeneration
Phosphoproteomics
neurodegeneration
metabolism [Neurites]
3. Good health
Cell biology
Neuroprotective Agents
drug effects [Microtubules]
metabolism [Neurons]
lcsh:Medicine (General)
metabolism [Alzheimer Disease]
Signal Transduction
drug effects [Signal Transduction]
Neurite
induced pluripotent stem cells
Phenotypic screening
metabolism [Glycogen Synthase Kinase 3 beta]
metabolism [Microtubules]
CDK5
drug effects [Neurites]
Biology
Neuroprotection
Article
03 medical and health sciences
drug effects [Phosphorylation]
Alzheimer Disease
Genetics
medicine
Neurites
drug effects [Neurons]
Animals
Humans
ddc:610
Neuroinflammation
Inflammation
Glycogen Synthase Kinase 3 beta
pharmacology [Neuroprotective Agents]
Cyclin-dependent kinase 5
GSK3β
drug therapy [Inflammation]
Cyclin-Dependent Kinase 5
Cell Biology
medicine.disease
biology.organism_classification
030104 developmental biology
drug effects [Cytoskeleton]
lcsh:Biology (General)
nervous system
Nerve Degeneration
metabolism [Cyclin-Dependent Kinase 5]
drug therapy [Nerve Degeneration]
ALS
030217 neurology & neurosurgery
Developmental Biology
Subjects
Details
- ISSN :
- 22136711
- Database :
- OpenAIRE
- Journal :
- Stem Cell Reports
- Accession number :
- edsair.doi.dedup.....98a62262d3eda3ad763fb4978fc17dde
- Full Text :
- https://doi.org/10.1016/j.stemcr.2019.01.015